Institutional Ownership
Tyra Biosciences Inc
CUSIP 90240B106COMTYRAQ1 2026
13D / 13G Filings
43
Schedule 13D/13G on record
Beneficial Filers
17
Distinct reporting persons
Largest Stake
22.4%
Max % of class reported
Institutional Holders
157
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
43 filings · latest Mar 6, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 6, 2026 | Ra Capital Management, L.P. | 13D/A | 21.2% | — | SEC |
| 2 | Feb 20, 2026 | Farallon Capital Partners, L.P. | 13G | 5.6% | 2.98M | SEC |
| 3 | Feb 17, 2026 | Biotechnology Value Fund L P | 13G/A | 4.0% | 2.13M | SEC |
| 4 | Feb 13, 2026 | Todd Harris | 13G | 5.1% | 2.81M | SEC |
| 5 | Feb 13, 2026 | Canaan Xi L.P. | 13G/A | 5.5% | 2.93M | SEC |
| 6 | Nov 14, 2025 | Commodore Capital LP | 13G/A | 11.0% | 3.38M | SEC |
| 7 | Nov 14, 2025 | Vestal Point Capital, LP | 13G/A | 4.5% | 2.42M | SEC |
| 8 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 5.4% | 2.86M | SEC |
| 9 | Jun 6, 2025 | Ra Capital Management, L.P. | 13D/A | 22.4% | — | SEC |
| 10 | May 15, 2025 | Vestal Point Capital, LP | 13G | 5.4% | 2.88M | SEC |
33 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Tyra Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 12.20M | $467.21M |
| 2 | Fmr LLC | 7.75M | $296.73M |
| 3 | Nextech Invest, Ltd. | 4.06M | $155.34M |
| 4 | Janus Henderson Group PLC | 3.89M | $148.87M |
| 5 | Alta Partners Management Company, L.P. | 3.82M | $146.44M |
| 6 | Farallon Capital Management LLC | 3.58M | $137.15M |
| 7 | Tcg Crossover Management, LLC | 3.25M | $124.44M |
| 8 | Commodore Capital LP | 2.48M | $94.79M |
| 9 | Blackrock, Inc. | 2.22M | $84.95M |
| 10 | Paradigm Biocapital Advisors LP | 2.05M | $78.71M |